SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    CanXChange Introduces Revolutionary CX Financing Service, Redefining Industry Standards

    By

    CanXChange, the largest B2B cannabis platform in Europe and a leading financial technology company, is proud to announce the launch of its newest service, CX Financing. This innovative product is set to transform the receivables financing landscape, offering exclusive credit terms to our esteemed partners and clients.

    As a trusted name in the industry, CanXChange is dedicated to providing innovative solutions that meet the evolving needs of cannabis businesses. With CX Financing, we are taking a bold step towards revolutionizing the receivables financing experience.

    To find out more about CanXChange, visit: www.linkedin.com/company/canxchange

    Alex Arkentis, CEO and Co-Founder of CanXChange explained, “what sets CX Financing apart is its unique approach to credit terms. Unlike traditional financing options, CX Financing offers our partners and clients the flexibility they need to manage their cash flow effectively. With competitive interest rates and customized credit terms, cannabis businesses and industry professionals can now access the working capital they require without sacrificing their financial stability.”

    CX Financing offers exclusive credit terms to both buyers and sellers in the cannabis industry, a unique offering that sets CanXChange apart from its competitors. Our advanced technology platform streamlines the process, reducing paperwork and providing real-time access to funds. After a thorough eligibility assessment, buyers and sellers can receive prompt payment with flexible repayment terms at a competitive rate.

    Sellers can benefit from the advantage of buyers’ strong credit rating and enjoy a sustainable payment solution for long-term financial ease. Meanwhile, buyers can enjoy extended credit terms, which will strengthen supply chain stability and supplier relationships, as well as boost the supply chain’s ESG rating.

    “We are thrilled to introduce CX Financing to the market,” said Sigfried Legeay, CFO and Co-Founder of CanXChange. “With this new service we are proud to continue our mission of revolutionizing the cannabis industry and our commitment to innovation, while providing our partners and clients with the tools they need to thrive in today’s competitive landscape”, he added.

    At CanXChange, we understand that businesses face various challenges when it comes to managing their receivables. With CX Financing, we aim to alleviate these challenges by offering a seamless and efficient financing experience. It is designed for cannabis businesses of all sizes. Whether it’s to support growth, bridge cash flow gaps, or seize new opportunities, CX Financing offers the financial flexibility that cannabis businesses of all sizes require.

    To learn more about CX Financing and enquire about an eligibility assessment, visit our website at https://www.canxchange.eu/contact-us or contact our customer support team at info@canxchange.eu.

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Ben Stevens

    Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free